Banner
Drug Manufacturers – Major

Abbott Laboratories, Inc. (NYSE: ABT) – FYE 12/2021 – FAIRLY VALUED – The stock is currently trading at levels above my most recent $72 initiate target, but below my most recent $128 reduce target. Please See Linked PDF Worksheet.
Revised on 07/24/2022

AbbVie, Inc. (NYSE: ABBV) – FYE 12/2021 – FAIRLY VALUED – The stock is currently trading at levels above my most recent $111 initiate target, but below my most recent $198 reduce target. Please See Linked PDF Worksheet.
Revised on 03/22/2022

Bristol Meyers Squibb Company, Inc. (NYSE: BMY) – FYE 12/2021 – UNDER VALUED – The stock is currently trading at levels below my most recent $119 initiate target. Please See Linked PDF Worksheet.
Revised on 07/25/2022

Johnson and Johnson (NYSE: JNJ) – FYE 12/2021 – FAIRLY VALUED – The stock is currently trading at levels above my most recent $119 initiate target, but below my most recent $212 reduce target. Please See Linked PDF Worksheet.
Revised on 04/16/2022

Please note that worksheets are updated basis the most current SEC 10-K ANNUAL filing.